Search hospitals > Delaware > Newark
Christiana Care Health System-Christiana Hospital
Claim this profileNewark, Delaware 19711
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Leukemia
466 reported clinical trials
14 medical researchers
Summary
Christiana Care Health System-Christiana Hospital is a medical facility located in Newark, Delaware. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Leukemia and other specialties. Christiana Care Health System-Christiana Hospital is involved with conducting 466 clinical trials across 651 conditions. There are 14 research doctors associated with this hospital, such as Gregory A. Masters, Michael Guarino, MD, Mark E. Borowsky, and Anthony Sciscione, DO.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Gregory A. MastersHelen F Graham Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
123 reported clinical trials
201 drugs studied
Michael Guarino, MDChristiana Hospital6 years of reported clinical research
Studies Pancreatic Cancer
Studies Hemangiopericytoma
4 reported clinical trials
7 drugs studied
Mark E. BorowskyJersey Shore Medical Center12 years of reported clinical research
Studies Serous Cystadenocarcinoma
Studies Adenocarcinoma
3 reported clinical trials
11 drugs studied
Anthony Sciscione, DOChristiana Hospital1 year of reported clinical research
Studies Premature Birth
Studies Preterm Birth
2 reported clinical trials
2 drugs studied
Clinical Trials running at Christiana Care Health System-Christiana Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Cancer
Squamous Cell Carcinoma
Anal Cancer
Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Oropharyngeal Carcinoma
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Christiana Care Health System-Christiana Hospital?
Christiana Care Health System-Christiana Hospital is a medical facility located in Newark, Delaware. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Leukemia and other specialties. Christiana Care Health System-Christiana Hospital is involved with conducting 466 clinical trials across 651 conditions. There are 14 research doctors associated with this hospital, such as Gregory A. Masters, Michael Guarino, MD, Mark E. Borowsky, and Anthony Sciscione, DO.
Where is Christiana Care Health System-Christiana Hospital located?
**Christiana Care Health System-Christiana Hospital**
Location: 4755 Ogletown-Stanton Road, Newark, DE 19718.
Christiana Hospital in Newark, Delaware, serves as the primary location for Christiana Care Health System, complemented by additional facilities such as the HealthCare Center at Christiana nearby.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Christiana Care Health System-Christiana Hospital, contact the billing department at billing@uhcc.com or call (410) 392-7033, Monday to Friday, 8 a.m. to 4:30 p.m. Financial counselors are available to guide you through the application process, which can be initiated in person, by phone, or by requesting materials in English or Spanish through their website, mail, or in person. For specific assistance, contact a representative at 302-623-7440, available Monday through Friday, 9 a.m. to 4 p.m.
What insurance does Christiana Care Health System-Christiana Hospital accept?
Christiana Care Health System-Christiana Hospital accepts a wide range of insurance plans, including but not limited to Aetna HMO/POS, Amerihealth HMO/Keystone, BCBS – DE/MD/Out of Area, Cigna HMO/PPO, and United Healthcare. Please note that as of January 1, 2024, ChristianaCare services will be out-of-network for Humana Medicare Advantage plans, with the exception of emergency services. Services will continue to be in-network for Humana Medicare Supplemental Plan members.
What awards or recognition has Christiana Care Health System-Christiana Hospital received?
Christiana Care Health System-Christiana Hospital in Newark, Delaware, is celebrated for its exceptional healthcare services, earning accolades such as the 2nd best health system for diversity and inclusion and the 29th best health system to work for in the United States by Forbes. It is also listed among America's 50 Best Hospitals by Healthgrades and consistently ranks high in national quality ratings by U.S. News & World Report and Newsweek. The hospital holds accreditations from prestigious organizations like The Joint Commission, The American Association of Blood Banks, and The American College of Radiology.